Again, this partially reflects the insights already gained from other studies, as particularly ASXL1, SRSF2 and TP53 are known—among others—to be associated with a higher probability to develop AML in the background of MPN [5,9,42]. Here, ASXL1 is linked to myeloproliferative neoplasm.